Accelerating your path to ASEAN market entry
Leverage Malaysia as a sophisticated launchpad to access a $3.6T combined GDP and 650M+ consumers. We transform complex regional barriers into a single, streamlined point of entry.
Leverage Malaysia as a sophisticated launchpad to access a $3.6T combined GDP and 650M+ consumers. We transform complex regional barriers into a single, streamlined point of entry.
One partnership provides a foundation for the entire region. Successful Malaysian MDA registration often accelerates regulatory approvals in neighboring markets through harmonized standards.
Establish your ASEAN presence with Malaysian MDA approval, legal infrastructure, and operational base—designed for regional expansion from day one.
Malaysian approval leverages ASEAN Medical Device Directive (AMDD) harmonization, accelerating pathways to Singapore, Indonesia, Thailand, and beyond.
Transform your single-country launch into a coordinated regional rollout, leveraging shared distributor networks and clinical training infrastructure.
International regulatory expertise and operational infrastructure to ensure seamless ASEAN-wide compliance and market execution
Technical file preparation for ASEAN-wide compliance with international post-market surveillance infrastructure.
Immediate legal entity (Sdn Bhd) and import licensing to bypass 12-24 month setup delays across the region.
KOL engagement and regional training centers to educate medical professionals across borders and build clinical credibility.
Our 6-point evaluation framework eliminates partner selection risk by ensuring strict alignment with international standards and local execution capability
1
Verified capital adequacy. We audit partner liquidity to ensure sustained inventory levels and the capacity for long-term expansion.
2
Technical readiness. We require the infrastructure to support complex active devices, local bio-engineering, and professional clinical training.
3
Strict regulatory adherence. We verify alignment with ISO/GDPMD standards to guarantee total product integrity and patient safety.
4
Specialist network access. We leverage proven relationships with Vascular and Orthopaedic KOLs to ensure immediate regional market entry.
5
Proven commercial execution. We verify sales force competency to ensure your technology is actively championed, not just listed.
6
Mission alignment. We partner with organizations committed to evidence-based medicine to protect and grow your brand equity.
Traditional market entry requires $200K-$300K in upfront costs. MintCare eliminates this financial risk entirely through our success-based partnership model
This aggressive timeline is achievable only through MintCare’s established infrastructure and proven processes. Traditional approaches typically require 18-24 months to reach market launch.
Schedule a strategic consultation to discuss your ASEAN market entry roadmap